KD Logo

Insider Selling: GORMAN KEVIN CHARLES, Neurocrine Biosciences, Inc [NBIX] Director divested 146,105 shares

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neurocrine Biosciences, Inc shares valued at $21,836,503 were sold by GORMAN KEVIN CHARLES on Jan 27 ’25. At $149.46 per share, GORMAN KEVIN CHARLES sold 146,105 shares. The insider’s holdings dropped to 514,596 shares worth approximately $77.54 million following the completion of this transaction.

Also, KEVIN CHARLES GORMAN purchased 146,105 shares, netting a total of over 21,730,197 in proceeds.

Before that, Gano Kyle had sold 65,000 shares from its account. In a trade valued at $9,197,550, the Chief Executive Officer traded Neurocrine Biosciences, Inc shares for $141.50 each. Upon closing the transaction, the insider’s holdings decreased to 65,000 shares, worth approximately $20.4 million.

Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late August. As of April 24, 2024, Wells Fargo has increased its “an Equal weight” rating to a “an Overweight” for NBIX.

Analyzing NBIX Stock Performance

During the last five days, there has been a surge of approximately 2.67%. Over the course of the year, Neurocrine Biosciences, Inc shares have jumped approximately 10.39%. Shares of the company reached a 52-week high of $153.34 on 01/29/25 and a 52-week low of $136.13 on 01/06/25. A 50-day SMA is recorded $134.25, while a 200-day SMA reached $133.31. Nevertheless, trading volume fell to 0.99 million shares from 1.1 million shares the previous day.

Support And Resistance Levels for Neurocrine Biosciences, Inc (NBIX)

According to the 24-hour chart, there is a support level at 148.73, which, if violated, would cause prices to drop to 146.77. In the upper region, resistance lies at 152.99. The next price resistance is at 155.29. RSI (Relative Strength Index) is 75.02 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 4.97, which suggests the price will increase in the coming days. Percent R is at 16.28%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.

Most Popular